Scientific paper - Review paper
Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review)
Molecular Medicine Reports, 24 (2021), 2; 611. https://doi.org/10.3892/mmr.2021.12250

Nadalin, Sergej; Jakovac, Hrvoje; Peitl, Vjekoslav; Karlović, Dalibor; Buretić-Tomljanović, Alena

Linked objects
COVID-19 | Virtual collection
Cite this document

Nadalin, S., Jakovac, H., Peitl, V., Karlović, D. & Buretić Tomljanović, A. (2021). Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review). Molecular Medicine Reports, 24. (2). doi: 10.3892/mmr.2021.12250

Nadalin, Sergej, et al. "Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review)." Molecular Medicine Reports, vol. 24, no. 2, 2021. https://doi.org/10.3892/mmr.2021.12250

Nadalin, Sergej, Hrvoje Jakovac, Vjekoslav Peitl, Dalibor Karlović and Alena Buretić Tomljanović. "Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review)." Molecular Medicine Reports 24, no. 2 (2021). https://doi.org/10.3892/mmr.2021.12250

Nadalin, S., et al. (2021) 'Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review)', Molecular Medicine Reports, 24(2). doi: 10.3892/mmr.2021.12250

Nadalin S, Jakovac H, Peitl V, Karlović D, Buretić Tomljanović A. Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review). Molecular Medicine Reports [Internet]. 2021 June 28 [cited 2024 October 29];24(2). doi: 10.3892/mmr.2021.12250

S. Nadalin, H. Jakovac, V. Peitl, D. Karlović and A. Buretić Tomljanović, "Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review)", Molecular Medicine Reports, vol. 24, no. 2, June 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:410278. [Accessed: 29 October 2024]

Please login to the repository to save this object to your list.